Pediatric Neurology
Volume 25, Issue 3 , Pages 239-241 , September 2001

Kawasaki disease with predominant central nervous system involvement

  • Brahim Tabarki, MD

      Affiliations

    • Services de Pédiatrie et de Cardiologie; Hôpital Farhat-Hached; Sousse, Tunisia
    • Corresponding Author InformationCommunication should be addressed to: Dr. Tabarki; Saint-Luc University Hospital; Hippocrate Avenue 10; 1200 Brussels, Belgium
    • ,
  • Abdallah Mahdhaoui, MD

      Affiliations

    • Services de Pédiatrie et de Cardiologie; Hôpital Farhat-Hached; Sousse, Tunisia
    • ,
  • Habib Selmi, MD

      Affiliations

    • Services de Pédiatrie et de Cardiologie; Hôpital Farhat-Hached; Sousse, Tunisia
    • ,
  • Moncef Yacoub, MD

      Affiliations

    • Services de Pédiatrie et de Cardiologie; Hôpital Farhat-Hached; Sousse, Tunisia
    • ,
  • Ahmed S Essoussi, MD

      Affiliations

    • Services de Pédiatrie et de Cardiologie; Hôpital Farhat-Hached; Sousse, Tunisia

Received 29 November 2000 ,Accepted 3 April 2001.

References 

  1. Terasawa K, Ichinose E, Matsuishi T, Kato H. Neurological complications in Kawasaki disease. Brain Dev. 1983;5:371–374
  2. Laxer RM, Dunn HG, Flodmark O. Acute hemiplegia in Kawasaki disease and infantile polyarteritis nodosa. Dev Med Child Neurol. 1984;26:814–818
  3. Takagi K, Umezawa T, Saji T, Morooka K, Matsuo N. Meningoencephalitis in Kawasaki disease. No To Hattatsu. 1990;22:429–435
  4. Aoki N. Subdural effusion in the acute stage of Kawasaki disease. Surg Neurol. 1988;29:216–217
  5. Sundel RP, Newburger JW, McGill T, et al.  Sensorineural hearing loss associated with Kawasaki disease. J Pediatr. 1990;117:371–377
  6. Shimura T, Toyama K, Shirai N, Nakashima T, Arima H. A case of mucocutaneous lymph node syndrome with Moyamoya disease. J Pediatr Pract. 1976;39:1420–1424
  7. Dengler LD, Capparelli EV, Bastian JF, et al.  Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J. 1998;17:478–481
  8. Kato H, Koike S, Yokoyama T. Kawasaki disease (Effect of treatment on coronary artery involvement). Pediatrics. 1979;63:175–179
  9. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465–469
  10. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr. 2000;137:723–726
  11. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med. 2000;154:694–699
  12. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996;128:146–149
  13. Ichiyama T, Nishikawa M, Hayashi T, Koga M, Tashiro N, Furukawa S. Cerebral hypoperfusion during acute Kawasaki disease. Stroke. 1998;29:1320–1321
  14. Amano S, Hazama F. Neural involvement in Kawasaki disease. Acta Pathol Jpn. 1980;30:365–373
  15. Newburger JW, Takahashi M, Burns JC, et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341–347

PII: S0887-8994(01)00290-9

Pediatric Neurology
Volume 25, Issue 3 , Pages 239-241 , September 2001

Article Tools

* Image Usage & Resolution